On June 6, 2024, Christopher Towers resigned from the Board of Directors (the ?Board?) of Intelligent Bio Solutions Inc. (the ?Company?), effective June 7, 2024. In connection with his resignation, Mr. Towers also resigned from the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee of the Board. At the time of his resignation, Mr. Towers was the Chairman of the Audit Committee and the Nominating and Corporate Governance Committee.

The Company is grateful to Mr. Towers for his service and contributions to the Board. On June 7, 2024, upon recommendation of the Nominating and Corporate Governance Committee, the Board appointed Nicola Fraser to the Board to fill the vacancy created by Mr. Tower?s resignation. Ms. Fraser was also appointed by the Board to the Audit Committee and will serve as the Chair of the Audit Committee.

The Board determined that Ms. Fraser is ?independent? within the meaning of the rules of the Nasdaq Stock Market. Ms. Fraser was appointed until her successor is duly elected and qualified.

Below is certain biographical information regarding Ms. Fraser. Nicola Fraser, age 48, is currently the Managing Partner of NextKey Services LLC, a financial consulting company she co-founded in 2019 that advises high-growth companies on strategic financial matters. From 2015 to 2018, prior to founding NextKey, Ms. Fraser served as Executive Director ?

Finance, Regulatory Capital at JP Morgan Chase. While at JP Morgan Chase and in her previous senior executive positions at Fannie Mae and Deloitte, she led significant financial transformations and regulatory compliance initiatives. Ms. Fraser is an active CPA, licensed in Texas, and holds an AICPA Chartered Global Management Accountant (CGMA) designation.

Other Committee Appointment:: On June 7, 2024, to fill the vacancies caused by Mr. Tower?s resignation, the Board appointed Steven Boyages to both the Compensation Committee and the Nominating and Corporate Governance Committee. Mr. Boyages was also appointed as the Chair of the Nominating and Corporate Governance Committee. As a result of the new committee appointments, the committees of the Board of Directors now consist of the following members: Audit Committee: Nicola Fraser (Chair), Lawrence Fisher, and Jonathan Hurd; Compensation Committee: Jonathan Hurd (Chair), Steven Boyages, and Lawrence Fisher; Nominating and Corporate Governance Committee: Steven Boyages (Chair), Jonathan Hurd, and Jason Isenberg.